| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 MYNN GMEB2 ZIM3 ZNF840P ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 ZNF723 ZNF664 ZNF107 ZNF114 | 5.23e-08 | 1244 | 94 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 MYNN GMEB2 ZIM3 ZNF840P ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 ZNF723 ZNF664 ZNF107 ZNF114 | 7.64e-08 | 1271 | 94 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 MYNN GMEB2 ZIM3 ZNF840P ZNF675 ZFHX4 SP140L ZNF732 ZNF728 ZFP1 SP5 ZNF770 PLAGL2 ZNF723 ZNF664 ZNF107 ZNF114 | 1.09e-07 | 1412 | 94 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 MYNN GMEB2 ZIM3 ZNF840P ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 ZNF723 ZNF664 ZNF107 ZNF114 | 8.19e-07 | 1459 | 94 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.39e-04 | 118 | 94 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF597 ZNF484 GLIS3 ZNF485 ZNF521 ZNF840P ZNF770 PLAGL2 ZNF107 | 1.29e-03 | 560 | 94 | 9 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF597 ZNF484 GLIS3 ZNF485 ZNF521 ZNF840P ZNF770 PLAGL2 ZNF107 | 1.39e-03 | 566 | 94 | 9 | GO:0001216 |
| Domain | Znf_C2H2 | ZNF597 TRIT1 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFR2 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 3.76e-12 | 805 | 91 | 23 | IPR007087 |
| Domain | - | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 8.81e-12 | 679 | 91 | 21 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 1.29e-11 | 693 | 91 | 21 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 1.33e-11 | 694 | 91 | 21 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF597 TRIT1 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 1.45e-11 | 777 | 91 | 22 | PS00028 |
| Domain | Znf_C2H2-like | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFR2 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 2.31e-11 | 796 | 91 | 22 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFR2 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 3.09e-11 | 808 | 91 | 22 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZFHX4 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 1.03e-10 | 775 | 91 | 21 | PS50157 |
| Domain | zf-C2H2_6 | ZNF597 ZNF423 ZNF521 MYNN ZIM3 ZNF675 ZNF732 ZNF728 ZNF667 ZNF770 PLAGL2 ZNF107 ZNF114 | 3.96e-09 | 314 | 91 | 13 | PF13912 |
| Domain | KRAB | ZNF597 ZNF484 ZNF485 ZIM3 ZNF675 ZNF732 ZNF728 ZFP1 ZNF667 ZNF114 | 9.57e-06 | 358 | 91 | 10 | PS50805 |
| Domain | KRAB | ZNF597 ZNF484 ZNF485 ZIM3 ZNF675 ZNF732 ZNF728 ZFP1 ZNF667 ZNF114 | 9.57e-06 | 358 | 91 | 10 | PF01352 |
| Domain | ZnF_U1 | 1.14e-05 | 29 | 91 | 4 | SM00451 | |
| Domain | Znf_U1 | 1.14e-05 | 29 | 91 | 4 | IPR003604 | |
| Domain | KRAB | ZNF597 ZNF484 ZNF485 ZIM3 ZNF675 ZNF732 ZNF728 ZFP1 ZNF667 ZNF114 | 1.24e-05 | 369 | 91 | 10 | SM00349 |
| Domain | KRAB | ZNF597 ZNF484 ZNF485 ZIM3 ZNF675 ZNF732 ZNF728 ZFP1 ZNF667 ZNF114 | 1.27e-05 | 370 | 91 | 10 | IPR001909 |
| Domain | NPIP | 3.92e-05 | 14 | 91 | 3 | IPR009443 | |
| Domain | IQ | 3.99e-04 | 71 | 91 | 4 | PF00612 | |
| Domain | SAND_dom | 6.45e-04 | 8 | 91 | 2 | IPR000770 | |
| Domain | SAND | 6.45e-04 | 8 | 91 | 2 | PF01342 | |
| Domain | SAND | 6.45e-04 | 8 | 91 | 2 | PS50864 | |
| Domain | SAND | 6.45e-04 | 8 | 91 | 2 | SM00258 | |
| Domain | IQ | 6.59e-04 | 81 | 91 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 9.79e-04 | 90 | 91 | 4 | IPR000048 | |
| Domain | IQ | 1.11e-03 | 93 | 91 | 4 | PS50096 | |
| Domain | - | 1.50e-03 | 12 | 91 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 1.50e-03 | 12 | 91 | 2 | IPR010919 | |
| Domain | Myosin_tail_1 | 3.41e-03 | 18 | 91 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.41e-03 | 18 | 91 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.80e-03 | 19 | 91 | 2 | IPR027401 | |
| Domain | - | 3.80e-03 | 19 | 91 | 2 | 4.10.270.10 | |
| Domain | C2H2_Znf_fam | 6.04e-03 | 24 | 91 | 2 | IPR027775 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF597 ZNF484 COX4I1 SMURF1 ZNF485 ZNF521 ZIM3 ZNF675 ZNF732 ZFP1 ZNF667 ZNF770 ZNF664 OCLN ANAPC5 ZNF114 | 8.25e-05 | 1387 | 57 | 16 | M734 |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12393497 | ||
| Pubmed | 8.48e-06 | 251 | 100 | 7 | 29778605 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 2.45e-05 | 3 | 100 | 2 | 26788497 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 27569559 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 2.45e-05 | 3 | 100 | 2 | 11948212 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF597 ZMYND11 COX4I1 ZNF485 ZNF407 DTX3L NAA25 SP140L USP42 RRP12 ZNF664 OCLN USP6NL | 4.16e-05 | 1203 | 100 | 13 | 29180619 |
| Pubmed | Global gene expression patterns in mouse wolffian duct development. | 8.14e-05 | 5 | 100 | 2 | 16945627 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 14630787 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 23682123 | ||
| Pubmed | DDX31 COX4I1 CCDC18 HMMR CCDC77 RRP12 SYNE2 ASPM UGGT2 WDR12 PKN2 OCLN USP6NL TARS1 | 9.09e-05 | 1487 | 100 | 14 | 33957083 | |
| Pubmed | 9.69e-05 | 497 | 100 | 8 | 23414517 | ||
| Pubmed | 9.78e-05 | 31 | 100 | 3 | 16140986 | ||
| Pubmed | The neurotransmitter dopamine modulates vascular permeability in the endothelium. | 1.22e-04 | 6 | 100 | 2 | 18662404 | |
| Pubmed | An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. | 1.22e-04 | 6 | 100 | 2 | 19841260 | |
| Pubmed | Myosin IXa regulates epithelial differentiation and its deficiency results in hydrocephalus. | 1.22e-04 | 6 | 100 | 2 | 19828736 | |
| Pubmed | A genome-wide association study (GWAS) for bronchopulmonary dysplasia. | 1.29e-04 | 34 | 100 | 3 | 23897914 | |
| Pubmed | 1.65e-04 | 686 | 100 | 9 | 29987050 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 15887267 | ||
| Pubmed | 2.27e-04 | 8 | 100 | 2 | 24261709 | ||
| Pubmed | MYH3 CCDC150 MYNN FAM98B CCDC77 ZNF675 C9orf43 SYNE2 ASPM ANKRD30A UGGT2 PPP1R9B KDR | 2.52e-04 | 1442 | 100 | 13 | 35575683 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 19429912 | ||
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 12796502 | ||
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 6.03e-04 | 57 | 100 | 3 | 23080069 | |
| Pubmed | HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes. | 6.25e-04 | 13 | 100 | 2 | 26028220 | |
| Pubmed | 6.25e-04 | 13 | 100 | 2 | 20584329 | ||
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 7.12e-04 | 139 | 100 | 4 | 25476789 | |
| Pubmed | MEK kinase 1 regulates c-Jun phosphorylation in the control of corneal morphogenesis. | 7.28e-04 | 14 | 100 | 2 | 14627958 | |
| Pubmed | 7.28e-04 | 14 | 100 | 2 | 28893945 | ||
| Pubmed | 7.28e-04 | 14 | 100 | 2 | 26147758 | ||
| Pubmed | DDX31 COX4I1 ZNF485 ZNF521 SMG5 GMEB2 FHAD1 ZFHX4 RRP12 SYNE2 ZNF770 ZNF107 | 8.26e-04 | 1429 | 100 | 12 | 35140242 | |
| Pubmed | 9.57e-04 | 16 | 100 | 2 | 8467795 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 9.57e-04 | 16 | 100 | 2 | 17521568 | |
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 9.67e-04 | 67 | 100 | 3 | 22321011 | |
| Pubmed | 1.36e-03 | 19 | 100 | 2 | 18445686 | ||
| Pubmed | PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis. | 1.36e-03 | 19 | 100 | 2 | 28049691 | |
| Pubmed | Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. | 1.36e-03 | 19 | 100 | 2 | 11331305 | |
| Pubmed | 1.36e-03 | 19 | 100 | 2 | 22987638 | ||
| Pubmed | 1.49e-03 | 288 | 100 | 5 | 38496616 | ||
| Pubmed | 1.62e-03 | 591 | 100 | 7 | 15231748 | ||
| Pubmed | 1.66e-03 | 21 | 100 | 2 | 18353970 | ||
| Pubmed | 1.89e-03 | 181 | 100 | 4 | 37372979 | ||
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 2.54e-03 | 26 | 100 | 2 | 25820252 | |
| Pubmed | 2.85e-03 | 203 | 100 | 4 | 19953087 | ||
| Interaction | ZNF8 interactions | 1.02e-06 | 70 | 96 | 6 | int:ZNF8 | |
| Interaction | MYNN interactions | 1.57e-05 | 32 | 96 | 4 | int:MYNN | |
| Interaction | ZNF423 interactions | 2.57e-05 | 73 | 96 | 5 | int:ZNF423 | |
| Cytoband | 16p12.2 | 7.38e-05 | 37 | 100 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 5.64e-04 | 172 | 100 | 4 | chr16p12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 ZNF484 ZNF423 GLIS3 ZNF485 ZNF521 ZNF407 MYNN ZIM3 ZNF675 ZNF732 ZNF728 ZFP1 ZNF667 SP5 ZNF770 PLAGL2 ZNF664 ZNF107 ZNF114 | 6.89e-14 | 718 | 60 | 20 | 28 |
| GeneFamily | Small leucine rich repeat proteoglycans | 7.00e-04 | 12 | 60 | 2 | 573 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | TRIT1 ZNF423 L1TD1 CCDC150 ZNF521 CCDC77 CCDC112 C9orf43 NAA25 USP42 SULF1 RRP12 KLHL23 ASPM MLF1 PKN2 USP6NL TARS1 CCDC102A | 1.34e-05 | 1479 | 91 | 19 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.14e-07 | 199 | 99 | 7 | 07b8c33342c62afd9c63ec2d757cfa3ba65d2a98 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.97e-07 | 148 | 99 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.97e-07 | 148 | 99 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 187 | 99 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.92e-06 | 195 | 99 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 4.92e-06 | 195 | 99 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.92e-06 | 195 | 99 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-06 | 197 | 99 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 5.37e-06 | 198 | 99 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.53e-06 | 199 | 99 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.69e-06 | 200 | 99 | 6 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.69e-06 | 200 | 99 | 6 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 154 | 99 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 154 | 99 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 154 | 99 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 154 | 99 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 155 | 99 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 155 | 99 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-05 | 162 | 99 | 5 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 164 | 99 | 5 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 164 | 99 | 5 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 175 | 99 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.72e-05 | 177 | 99 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 178 | 99 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.25e-05 | 181 | 99 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.25e-05 | 181 | 99 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-05 | 181 | 99 | 5 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 5.25e-05 | 181 | 99 | 5 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 5.39e-05 | 182 | 99 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.39e-05 | 182 | 99 | 5 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.39e-05 | 182 | 99 | 5 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-05 | 183 | 99 | 5 | 07cebb0e186e1bff14ac2a6bb6f8412d4aaa2350 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.53e-05 | 183 | 99 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | E17.5-Epithelial-airway_epithelial_cell-club_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-05 | 183 | 99 | 5 | e8e85e5be909f9cd85a6a041190bfcb855dfa1a4 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-05 | 183 | 99 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.68e-05 | 184 | 99 | 5 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.68e-05 | 184 | 99 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.68e-05 | 184 | 99 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-05 | 184 | 99 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.68e-05 | 184 | 99 | 5 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.68e-05 | 184 | 99 | 5 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-05 | 184 | 99 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.68e-05 | 184 | 99 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 5.82e-05 | 185 | 99 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.82e-05 | 185 | 99 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.98e-05 | 186 | 99 | 5 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.98e-05 | 186 | 99 | 5 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.13e-05 | 187 | 99 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.13e-05 | 187 | 99 | 5 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.13e-05 | 187 | 99 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 188 | 99 | 5 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 188 | 99 | 5 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.29e-05 | 188 | 99 | 5 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 6.44e-05 | 189 | 99 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 6.44e-05 | 189 | 99 | 5 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.44e-05 | 189 | 99 | 5 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.44e-05 | 189 | 99 | 5 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.44e-05 | 189 | 99 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.61e-05 | 190 | 99 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.61e-05 | 190 | 99 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 190 | 99 | 5 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 191 | 99 | 5 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.77e-05 | 191 | 99 | 5 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.77e-05 | 191 | 99 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.77e-05 | 191 | 99 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.77e-05 | 191 | 99 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.77e-05 | 191 | 99 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Ciliated-cil-3|World / Class top | 6.94e-05 | 192 | 99 | 5 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-05 | 192 | 99 | 5 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 192 | 99 | 5 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.11e-05 | 193 | 99 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 7.11e-05 | 193 | 99 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.11e-05 | 193 | 99 | 5 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 194 | 99 | 5 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.29e-05 | 194 | 99 | 5 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 7.29e-05 | 194 | 99 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 194 | 99 | 5 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 7.47e-05 | 195 | 99 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.47e-05 | 195 | 99 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.47e-05 | 195 | 99 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 7.47e-05 | 195 | 99 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-05 | 195 | 99 | 5 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.65e-05 | 196 | 99 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| Disease | bronchopulmonary dysplasia | 3.91e-04 | 45 | 93 | 3 | MONDO_0019091 | |
| Disease | temporomandibular joint disorder | 4.35e-04 | 10 | 93 | 2 | EFO_0005279 | |
| Disease | uridine diphosphate measurement | 1.80e-03 | 20 | 93 | 2 | EFO_0010545 | |
| Disease | Arthrogryposis | 1.98e-03 | 21 | 93 | 2 | C0003886 | |
| Disease | age at menopause | 2.71e-03 | 302 | 93 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKSYKLHLQKNKSQK | 56 | A8MVM7 | |
| QKHIIHIKVKKLLFS | 61 | Q9UKF5 | |
| EHKKLQKVQATEKHQ | 406 | Q5SW79 | |
| IKKFKHVQNHEIKQL | 111 | Q6ZTR7 | |
| EHIIKKLIKENKKHQ | 206 | Q7Z3E2 | |
| AKIHNNVKKLQHQLK | 46 | Q8NEF3 | |
| VHHKQQLNLLKAKQK | 2236 | Q9NR09 | |
| HQESLSKTKLQIKKQ | 721 | Q96M83 | |
| IHKKLAKKNLHVIDL | 81 | Q8N8R7 | |
| QLVHAHKKADNKSKI | 1336 | Q9BXX3 | |
| NKIKELTKNLHHTQE | 266 | Q9BR77 | |
| KITNHQHKEYLNLKK | 2081 | Q8IZT6 | |
| HIKEQTKAKLFAKHQ | 1101 | Q9C0F0 | |
| KELKHKSQHLSNVLM | 331 | Q9UKD1 | |
| KVTTKINHHDKINGK | 161 | Q92617 | |
| NKRHILHSSKSLVKK | 141 | Q9H0B3 | |
| KKNHCKQLKSKLSHI | 496 | Q16625 | |
| KVTTKINHHDKINGK | 161 | F8W0I5 | |
| HIEVKQKKKSHGLLI | 366 | Q6ZRR7 | |
| HKLLQKLLVHCQKLK | 561 | Q9UJX4 | |
| KFVKHINHRSLEQKK | 511 | Q8N543 | |
| AAHIKSKSHLNQLKK | 411 | Q9H3H1 | |
| HINTHGSTKNKKQLK | 516 | Q6NUN7 | |
| AIIKVLIQKHSKSNH | 316 | Q8NH61 | |
| IKNLKKHKTKVHSGA | 511 | Q9NPC7 | |
| HHLKKLLNDKKILEN | 426 | Q6ZMV9 | |
| KVTTKINHHDKINGK | 161 | A8MRT5 | |
| KDIKTVKHKLQTHIG | 271 | Q9Y546 | |
| ALEHKKKIQKQLEHL | 416 | O15553 | |
| AHVKRPDLHKKTQSK | 766 | Q9H8H2 | |
| KVTTKINHHDKINGK | 161 | C9JG80 | |
| LLIKHWHQQCQKKIK | 201 | P29728 | |
| AKLLGHQNLKQKIKH | 626 | O75330 | |
| HQNLKQKIKHVVKLK | 631 | O75330 | |
| EKLQKVTQHHKKIEG | 941 | B1AJZ9 | |
| KEKFKNKIKLSGIHH | 71 | Q8NBE8 | |
| KIKNQKTQIKLHLSA | 891 | Q8NCX0 | |
| KNQLIVESAKNKKHL | 3221 | Q8TD57 | |
| KSLGKERKHLHQTKF | 456 | Q8TDB6 | |
| LAFEKAKKIHLEQHK | 631 | Q5T9S5 | |
| KNDHKHQKQLLSKIN | 181 | Q9P2H0 | |
| IHVSQHGKKKRKNSA | 146 | Q8TAL5 | |
| KHVKAHSSKEQQARK | 491 | Q8NEA6 | |
| LKHVHGKLKKQFQEK | 421 | Q96A19 | |
| LKHQSIIKSQLKHKD | 191 | Q9NSG2 | |
| SKVKDILSKVQKNHV | 176 | Q52LJ0 | |
| VFSKLKQLKKLHINH | 111 | P51884 | |
| QAKHTEHKTNLKEKT | 71 | Q8TDB4 | |
| VKITIHNSVKKQLHL | 126 | Q8NEG0 | |
| KKNVNQAKLSEHRHK | 586 | Q2VIQ3 | |
| VLNTVVNKHKDLKTH | 676 | P20807 | |
| HVKHLSASQKALKEK | 51 | P13073 | |
| KVTTKINHHDKINGK | 161 | A6NJU9 | |
| HLKEINLSHNKIKSQ | 116 | Q99983 | |
| HSLKKLSQKGRQKAH | 221 | Q8NGN8 | |
| VRHTGKIKALKIHKN | 266 | P26639 | |
| LAKHVKTHQNKKLKV | 371 | Q6BEB4 | |
| QKELNSLKKKHAKEH | 936 | Q15147 | |
| IQLIKTNKKHIHSRS | 91 | Q9UPR3 | |
| IKQVDSVLKHVKKHL | 1891 | Q8WXH0 | |
| EKLAHGHLKQTKSKV | 4756 | Q8WXH0 | |
| KLKQLLHKHQRKSIF | 701 | Q8WXD0 | |
| LLHTQNTSLIHTKKK | 1716 | P11055 | |
| LKKSNKKLEELHHKL | 86 | Q16513 | |
| HFKRHKLEISNAIKK | 56 | Q9H930 | |
| HKVEGHIQDKNKKKL | 281 | Q9H1P3 | |
| RHVKKSHSQELLKIK | 236 | Q9UPG8 | |
| IIRNKKHQKLKHQKE | 1186 | Q5JTH9 | |
| ITISVWNHKKIHKKQ | 76 | Q9HCE7 | |
| KHESKLVLRKLQQHQ | 356 | O75339 | |
| SSLLLHKKIHNGKKT | 266 | Q5HYK9 | |
| LIQHQKVHTKKKKLF | 401 | Q5HYK9 | |
| SHKAAIFKHQKIKNL | 166 | Q6P2D0 | |
| LTRHKIVHTKEKLNK | 511 | Q9UII5 | |
| TFIQKKNLIQHKKIH | 371 | Q96PE6 | |
| KLNLSLHKKTHTGQK | 431 | Q96PE6 | |
| HPKKQKITISIHNKL | 516 | Q9H9J4 | |
| NSVSHLHKLKKVLQE | 1516 | Q86UP3 | |
| HLQSSLHKEKTIKQA | 3416 | Q86UP3 | |
| EHHEKILNKFLSKLK | 236 | Q92738 | |
| SKHQKVFKLHAKLGK | 341 | Q9UPR6 | |
| KLNKHIKENHKNIPL | 576 | Q96K83 | |
| SIQLHLAVKHSNEKK | 736 | Q96K83 | |
| NKSSILNRHKIIHTK | 491 | P0DPD5 | |
| LNRHKIIHTKEKSQT | 496 | P0DPD5 | |
| HDRAHVIKKSKNKKT | 161 | P58340 | |
| VSVLNKHKKIHAGKK | 576 | P0DKX0 | |
| NSKLSRHQITHNKKK | 701 | A6NDX5 | |
| KIQSKLLKHKQIHTR | 226 | Q6IQ21 | |
| LTKHKKIHTGEKLQN | 551 | Q8TD23 | |
| LATQHKQLISQTKKK | 546 | Q15326 | |
| TTKLNRHKKIHTVEK | 71 | Q8N3J9 | |
| RKKHLNGLQHLKAKK | 21 | Q9UDW3 | |
| TIRSNLIKHQKIHTK | 786 | Q5JVG2 | |
| SKAALNELLKHIKHK | 1141 | Q6PGP7 | |
| KHQHKKLVNRDLKTQ | 266 | P35968 | |
| LVLHQKIHSGEKKHK | 171 | Q96LX8 | |
| SILKLTKHIKENHKN | 576 | Q2M1K9 | |
| ENHKNIPLAHSKKSK | 586 | Q2M1K9 | |
| KHIKRSKHLENAKKN | 751 | Q9C0G0 | |
| IINKLLKDKNEFHKH | 36 | Q9GZL7 | |
| IHKKHTCKINEIKKL | 141 | Q9NYU1 | |
| SNVAKHKKIHTGEKL | 291 | B4DXR9 | |
| EKGVKKQEKLKSHLH | 686 | Q8IWU6 | |
| RSSALKQHKKIHNKE | 421 | Q8NCK3 | |
| VLTQKQKKQHSVLHL | 106 | O75888 | |
| HLNKHLRKHVVQKKP | 346 | Q8NC26 | |
| KKLVKHQVVHKTQEE | 521 | Q5T7N2 | |
| QDRITKSLLHLHKKK | 871 | B2RTY4 | |
| IQQADKLLKKHKDLH | 31 | Q14CX7 | |
| KLVHKFKELQIKHAV | 666 | Q96SB3 |